Accessibility Menu
 
Dimerix logo

Dimerix

(ASX) DXB

Current Price$0.34
Market Cap$216.14M
Since IPO (2015)+87%
5 YearN/A
1 Year+3%
1 Month-4%

Dimerix Financials at a Glance

Market Cap

$216.14M

Revenue (TTM)

$8.15M

Net Income (TTM)

$39.62M

EPS (TTM)

$-0.03

P/E Ratio

-13.24

Dividend

$0.00

Beta (Volatility)

-0.01 (Low)

Price

$0.34

Volume

589,786

Open

$0.35

Previous Close

$0.34

Daily Range

$0.34 - $0.36

52-Week Range

$0.29 - $0.79

DXB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Dimerix

Industry

Biotechnology

CEO

Nina Webster, PhD, EMBA

Headquarters

Fitzroy, VIC 3065, AU

DXB Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

-5%

Net Income Margin

-2%

Return on Equity

-595%

Return on Capital

-78%

Return on Assets

-25%

Earnings Yield

-7.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$216.14M

Shares Outstanding

600.40M

Volume

589.79K

Short Interest

0.00%

Avg. Volume

993.52K

Financials (TTM)

Gross Profit

$1.25M

Operating Income

$36.34M

EBITDA

$36.22M

Operating Cash Flow

$39.05M

Capital Expenditure

$21.01K

Free Cash Flow

$39.03M

Cash & ST Invst.

$68.28M

Total Debt

$97.48K

Dimerix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.12M

+1490.8%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$216.14M

N/A

Market Cap/Employee

N/A

N/A

Employees

0

N/A

Net Income

$15.97M

-139.3%

EBITDA

$21.73M

-223.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$38.45M

+187.4%

Accounts Receivable

$1.49M

+452.1%

Inventory

$0.00

+100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$33.42K

-97.7%

Return on Assets

-25.26%

N/A

Return on Invested Capital

-78.42%

N/A

Free Cash Flow

$29.86M

-413.6%

Operating Cash Flow

$29.86M

-413.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SPL.AXStarpharma Holdings Limited
$0.52+0.98%
ARX.AXAroa Biosurgery Limited
$0.53+0.00%
OCC.AXOrthocell Limited
$0.82-3.53%
MVF.AXMonash IVF Group Limited
$0.67+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
NOKNokia
$9.55+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.78-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%

Questions About DXB

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.